Abstract 4361628: Prognostic Value of Preprocedural Pulmonary Artery to Ascending Aorta Ratio in Patients Undergoing Mitral Valve Transcatheter Edge-to-edge Repair

H Hiroki Uehara (Hokkaido University, Sapporo, Japan) T Toshiyuki Nagai S So Sasaki (Hokkaido University, Sapporo, Japan) K Kento Tamano (Hokkaido University, Sapporo, Japan) T Toshifumi Tamura (Hokkaido University, Sapporo, Japan) A Akinori Takahashi T Takeshi Hamaya (Hokkaido University, Sapporo, Japan) Y Yuki Mori Y Yutaro Yasui (Hokkaido University, Sapporo, Japan) S Sakae Takenaka S Suguru Ishizaka (Hokkaido University, Sapporo, Japan) Y Yuta Kobayashi A Atsushi Tada (Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN.) K Kiwamu Kamiya (Hokkaido University, Sapporo, Japan) T Toshihisa Anzai

Abstract

Background: The pulmonary artery to ascending aorta ratio (PA/Ao), measurable by chest computed tomography (CT) was associated with clinical outcomes in patients with heart failure (HF). However, it is unclear whether the preprocedural PA/Ao is associated with postprocedural clinical outcomes in patients undergoing transcatheter edge-to-edge repair (M-TEER). Methods: We retrospectively examined 73 consecutive patients who underwent M-TEER for severe mitral regurgitation between April 2020 and March 2025. Chest CT performed within 3 months before the procedure was used to measure the diameters of the main PA and Ao. Transverse axial main pulmonary arterial diameter and minimum ascending aortic diameter were both measured at the level of PA bifurcation ( Figure 1 ). The PA/Ao was calculated as the former divided by the latter. Patients were divided into two groups: higher PA/Ao (≥1.0) and lower PA/Ao (<1.0). The primary outcome was a composite of all-cause death and hospitalization for worsening HF. Results: The median age was 77 years, and 36 patients (49.3%) were male. The median left ventricular ejection fraction (LVEF) was 33%. The median PA diameter, Ao diameter, and PA/Ao were 29mm, 35mm, and 0.85, respectively. There were no significant differences in age, LVEF, renal function, mitral effective regurgitant orifice area, left ventricular end-diastolic volume index, and N-terminal pro–B-type natriuretic peptide level between the groups. Patients with higher PA/Ao showed higher mean PA pressure and pulmonary capillary wedge pressure compared to those with lower PA/Ao. During a median follow-up of 541 (interquartile range 245–1101) days, the primary outcome occurred in 26 patients. Patients with higher PA/Ao had significantly higher incidence of the primary outcomes compared to those with lower PA/Ao ( Figure 2 ). A multivariable Cox regression analysis showed that higher PA/Ao was independently associated with a higher risk of primary outcome even after adjustment for prognostic covariates including age and LVEF (hazard ratio 4.18, 95% confidence interval 1.85-9.44, P = 0.001). Conclusions: A higher preprocedural PA/Ao ratio measured by chest CT was independently associated with an increased risk of adverse events in patients undergoing M-TEER, highlighting its potential role as a simple imaging-based prognostic surrogate in this population.

Article Details

Journal Circulation
Volume / Issue Vol. 152, Issue Suppl_3
Published November 04, 2025
ISSN 0009-7322
Publisher Lippincott Williams & Wilkins

Journal Info

Circulation

Lippincott Williams & Wilkins

ISSN: 0009-7322 Health Sciences

Authors (15)

H

Hiroki Uehara

Hokkaido University, Sapporo, Japan

T

Toshiyuki Nagai

S

So Sasaki

Hokkaido University, Sapporo, Japan

K

Kento Tamano

Hokkaido University, Sapporo, Japan

T

Toshifumi Tamura

Hokkaido University, Sapporo, Japan

A

Akinori Takahashi

T

Takeshi Hamaya

Hokkaido University, Sapporo, Japan

Y

Yuki Mori

Y

Yutaro Yasui

Hokkaido University, Sapporo, Japan

S

Sakae Takenaka

S

Suguru Ishizaka

Hokkaido University, Sapporo, Japan

Y

Yuta Kobayashi

A

Atsushi Tada

Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN.

K

Kiwamu Kamiya

Hokkaido University, Sapporo, Japan

T

Toshihisa Anzai